IO Biotech enrols 380 patients with advanced melanoma in phase 3 trial

13th November 2023 Uncategorised 0

The trial is evaluating an investigational cancer vaccine in combination with Keytruda

More: IO Biotech enrols 380 patients with advanced melanoma in phase 3 trial
Source: News